{"id":"https://openalex.org/W2590083441","doi":"https://doi.org/10.1200/jco.2013.31.6_suppl.386","title":"The role of FGF signaling in VEGF-pathway targeted therapy resistance: Data from patients and model systems.","display_name":"The role of FGF signaling in VEGF-pathway targeted therapy resistance: Data from patients and model systems.","publication_year":2013,"publication_date":"2013-02-20","ids":{"openalex":"https://openalex.org/W2590083441","doi":"https://doi.org/10.1200/jco.2013.31.6_suppl.386","mag":"2590083441"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.6_suppl.386","doi":"https://doi.org/10.1200/jco.2013.31.6_suppl.386","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.6_suppl.386","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058650905","display_name":"Thai H. Ho","orcid":"https://orcid.org/0000-0003-0023-2939","observed_orcids":["https://orcid.org/0000-0003-0023-2939"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thai Huu Ho","raw_affiliation_strings":["Mayo Clinic, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Scottsdale, AZ","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082148006","display_name":"Carla L. Warneke","orcid":"https://orcid.org/0000-0002-5012-2861","observed_orcids":["https://orcid.org/0000-0002-5012-2861"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carla L. Warneke","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021008372","display_name":"Anh G. Hoang","orcid":"https://orcid.org/0009-0008-2699-4337","observed_orcids":["https://orcid.org/0009-0008-2699-4337"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anh Hoang","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089628178","display_name":"Pheroze Tamboli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pheroze Tamboli","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5119607115","display_name":"Fen Wang","orcid":"https://orcid.org/0000-0002-9641-6611","observed_orcids":["https://orcid.org/0000-0002-9641-6611"]},"institutions":[{"id":"https://openalex.org/I125029298","display_name":"Texas A&M Health Science Center","ror":"https://ror.org/01tx6pn92","country_code":"US","type":"education","lineage":["https://openalex.org/I125029298","https://openalex.org/I91045830"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fen Wang","raw_affiliation_strings":["Texas A&M Health Science Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas A&M Health Science Center, Houston, TX","institution_ids":["https://openalex.org/I125029298"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007689146","display_name":"Eric W. Jonasch","orcid":"https://orcid.org/0000-0003-0943-2806","observed_orcids":["https://orcid.org/0000-0003-0943-2806"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Jonasch","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"6_suppl","first_page":"386","last_page":"386"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.6723999977111816,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.6723999977111816,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":0.18639999628067017,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.12680000066757202,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fgf-signaling","display_name":"FGF signaling","score":0.9580000042915344},{"id":"https://openalex.org/keywords/vegf-signaling-pathway","display_name":"VEGF pathway","score":0.9089999794960022},{"id":"https://openalex.org/keywords/targeted-therapy-resistance","display_name":"targeted therapy resistance","score":0.8040000200271606},{"id":"https://openalex.org/keywords/brivanib","display_name":"brivanib","score":0.8960000276565552},{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":0.8519999980926514},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9340000152587891},{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.925000011920929},{"id":"https://openalex.org/keywords/fgfr1","display_name":"FGFR1","score":0.9779999852180481},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7329999804496765},{"id":"https://openalex.org/keywords/mouse-xenograft-model","display_name":"xenograft mouse model","score":0.8309999704360962},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.7870000004768372}],"concepts":[{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.8837230205535889},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.8172014951705933},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8100568056106567},{"id":"https://openalex.org/C82867764","wikidata":"https://www.wikidata.org/wiki/Q24780051","display_name":"Fibroblast growth factor receptor","level":4,"score":0.7622615098953247},{"id":"https://openalex.org/C74373430","wikidata":"https://www.wikidata.org/wiki/Q24727126","display_name":"Fibroblast growth factor","level":3,"score":0.6791666746139526},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.640541672706604},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.555988073348999},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.5247963666915894},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5081212520599365},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.4384017288684845},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4301193058490753},{"id":"https://openalex.org/C49418065","wikidata":"https://www.wikidata.org/wiki/Q14914258","display_name":"Fibroblast growth factor receptor 1","level":4,"score":0.41004738211631775},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3470200300216675},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3084351420402527},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.12330088019371033},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.11569806933403015},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.10283896327018738}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.6_suppl.386","doi":"https://doi.org/10.1200/jco.2013.31.6_suppl.386","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.6_suppl.386","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2107798417","https://openalex.org/W2082407856","https://openalex.org/W2254659586","https://openalex.org/W2031563027","https://openalex.org/W2056694336","https://openalex.org/W2402660289","https://openalex.org/W2240854042","https://openalex.org/W2133786857","https://openalex.org/W2471958055","https://openalex.org/W2118471405"],"abstract_inverted_index":{"386":[0],"Background:":[1],"Angiogenesis":[2],"plays":[3],"a":[4,128,238,270],"role":[5],"in":[6,15,179,301],"tumor":[7,246,262,286],"growth":[8,19,25,82,92],"and":[9,22,35,80,97,105,120,158,195,268,284,299],"is":[10,231],"partly":[11],"mediated":[12],"by":[13,57,124,139,203],"factors":[14],"both":[16,31,282],"the":[17,69,113,213,245,259,265,302],"fibroblast":[18,81,91],"factor":[20,26,83,93],"(FGF)":[21],"vascular":[23],"endothelial":[24],"(VEGF)":[27],"pathways.":[28],"Brivanib":[29],"inhibits":[30],"VEGF":[32,119,289,300],"receptor":[33,84,122,290],"2":[34,86],"FGF":[36,77,121,171,234,278,298,308],"receptors":[37],"(FGFR)-1/2.":[38],"Methods:":[39],"Nephrectomy":[40],"material":[41],"from":[42,254],"40":[43],"patients":[44,180,227,305],"with":[45,133,152,166,176,181,185,191,229,233,251,306],"metastatic":[46,182],"renal":[47],"cell":[48],"carcinoma":[49],"(RCC)":[50],"receiving":[51],"sorafenib":[52,230],"\u00b1":[53],"interferon":[54],"was":[55,65,101,150,174],"assessed":[56],"immunohistochemical":[58],"(IHC)":[59],"staining.":[60],"The":[61,88,224,274,292],"Ariol":[62],"imaging":[63],"platform":[64],"used":[66],"to":[67,208,256,288,311],"stratify":[68],"specimens":[70],"based":[71],"on":[72,218],"intensity":[73],"of":[74,115,118,226,261,294,297,304],"staining":[75,149,161],"for":[76],"biomarkers:":[78],"FGFR-1":[79,148],"substrate":[85],"(pFRS2).":[87],"relationship":[89],"between":[90],"pathway":[94,172,235,279],"marker":[95],"levels":[96],"progression-free":[98],"survival":[99],"(PFS)":[100],"analyzed":[102],"using":[103],"Kaplan-Meier":[104],"Cox":[106],"proportional":[107],"hazards":[108],"regression":[109],"methods.":[110],"To":[111],"assess":[112],"efficacy":[114,293],"dual":[116,295],"targeting":[117],"signaling":[123],"brivanib,":[125,135],"we":[126],"treated":[127,184,190,228],"xenograft":[129,239],"RCC":[130,183,240],"mouse":[131,241],"model":[132],"sunitinib,":[134],"or":[136],"sunitinib":[137,194,219,255],"followed":[138],"brivanib.":[140],"Results:":[141],"Our":[142],"analysis":[143],"indicated":[144],"that":[145,159,277],"more":[146],"intense":[147],"associated":[151,165,175,232],"shorter":[153],"PFS":[154,167,178,225],"(p":[155,168,220],"=":[156,169,221],"0.0452),":[157],"pFRS2":[160],"were":[162,189],"not":[163],"significantly":[164],"0.2610).":[170],"activation":[173,280,309],"decreased":[177],"sorafenib.":[186],"Xenograft":[187],"mice":[188],"20":[192],"mg/kg":[193,210],"after":[196,216,248],"an":[197],"initial":[198,249],"stabilization":[199,214,266],"phase,":[200],"resistance":[201,272,287],"developed":[202],"day":[204],"20.":[205],"A":[206],"switch":[207],"30":[209],"brivanib":[211,243,257],"prolonged":[212,264],"phase":[215,267],"progression":[217],"0.0033).":[222],"Conclusions:":[223],"activation.":[236],"In":[237],"model,":[242],"overcame":[244,269],"escape":[247,263],"treatment":[250,312],"sunitinib.":[252],"Switching":[253],"at":[258],"time":[260],"sunitinib-induced":[271],"phenotype.":[273],"results":[275],"suggest":[276],"mediates":[281],"innate":[283],"acquired":[285],"inhibition.":[291],"inhibition":[296],"subset":[303],"increased":[307],"prior":[310],"requires":[313],"further":[314],"study.":[315]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2017-03-03T00:00:00"}